Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress

Thiago Bruder-Nascimento, Glaucia E. Callera, Augusto C. Montezano, Eric Jacques Belin de Chantemele, Rita C. Tostes, Rhian M. Touyz

Research output: Contribution to journalArticle

Abstract

Vascular inflammatory responses play an important role in several cardiovascular diseases. Of the many pro-inflammatory vasoactive factors implicated in this process, is aldosterone, an important mediator of vascular oxidative stress. Statins, such as atorvastatin, are cholesterol-lowering drugs that have pleiotropic actions, including anti-oxidant properties independently of their cholesterol-lowering effect. This study investigated whether atorvastatin prevents aldosterone-induced VSMC inflammation by reducing reactive oxygen species (ROS) production. Vascular smooth muscle cells (VSMC) from WKY rats were treated with 1 μM atorvastatin for 60 min or for 72 h prior to aldosterone (10 -7 mol/L) stimulation. Atorvastatin inhibited Rac1/2 and p47phox translocation from the cytosol to the membrane, as well as reduced aldosterone-induced ROS production. Atorvastatin also attenuated aldosterone-induced vascular inflammation and macrophage adhesion to VSMC. Similarly EHT1864, a Rac1/2 inhibitor, and tiron, ROS scavenger, reduced macrophage adhesion. Through its inhibitory effects on Rac1/2 activation and ROS production, atorvastatin reduces vascular ROS generation and inhibits VSMC inflammation. Our data suggest that in conditions associated with aldosterone-induced vascular damage, statins may have vasoprotective effects by inhibiting oxidative stress and inflammation.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalLife sciences
Volume221
DOIs
StatePublished - Mar 15 2019

Fingerprint

Oxidative stress
Aldosterone
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Oxidative Stress
Blood Vessels
Cells
Reactive Oxygen Species
Inflammation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Macrophages
Adhesion
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
Cholesterol
Inbred WKY Rats
Oxidants
Cytosol
Atorvastatin Calcium
Rats

Keywords

  • Inflammation
  • Mineralocorticoids
  • Redox signaling
  • Statins
  • Vascular

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress. / Bruder-Nascimento, Thiago; Callera, Glaucia E.; Montezano, Augusto C.; Belin de Chantemele, Eric Jacques; Tostes, Rita C.; Touyz, Rhian M.

In: Life sciences, Vol. 221, 15.03.2019, p. 29-34.

Research output: Contribution to journalArticle

Bruder-Nascimento, Thiago ; Callera, Glaucia E. ; Montezano, Augusto C. ; Belin de Chantemele, Eric Jacques ; Tostes, Rita C. ; Touyz, Rhian M. / Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress. In: Life sciences. 2019 ; Vol. 221. pp. 29-34.
@article{6ca4daf2beb9490fab42226e79c0e572,
title = "Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress",
abstract = "Vascular inflammatory responses play an important role in several cardiovascular diseases. Of the many pro-inflammatory vasoactive factors implicated in this process, is aldosterone, an important mediator of vascular oxidative stress. Statins, such as atorvastatin, are cholesterol-lowering drugs that have pleiotropic actions, including anti-oxidant properties independently of their cholesterol-lowering effect. This study investigated whether atorvastatin prevents aldosterone-induced VSMC inflammation by reducing reactive oxygen species (ROS) production. Vascular smooth muscle cells (VSMC) from WKY rats were treated with 1 μM atorvastatin for 60 min or for 72 h prior to aldosterone (10 -7 mol/L) stimulation. Atorvastatin inhibited Rac1/2 and p47phox translocation from the cytosol to the membrane, as well as reduced aldosterone-induced ROS production. Atorvastatin also attenuated aldosterone-induced vascular inflammation and macrophage adhesion to VSMC. Similarly EHT1864, a Rac1/2 inhibitor, and tiron, ROS scavenger, reduced macrophage adhesion. Through its inhibitory effects on Rac1/2 activation and ROS production, atorvastatin reduces vascular ROS generation and inhibits VSMC inflammation. Our data suggest that in conditions associated with aldosterone-induced vascular damage, statins may have vasoprotective effects by inhibiting oxidative stress and inflammation.",
keywords = "Inflammation, Mineralocorticoids, Redox signaling, Statins, Vascular",
author = "Thiago Bruder-Nascimento and Callera, {Glaucia E.} and Montezano, {Augusto C.} and {Belin de Chantemele}, {Eric Jacques} and Tostes, {Rita C.} and Touyz, {Rhian M.}",
year = "2019",
month = "3",
day = "15",
doi = "10.1016/j.lfs.2019.01.043",
language = "English (US)",
volume = "221",
pages = "29--34",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress

AU - Bruder-Nascimento, Thiago

AU - Callera, Glaucia E.

AU - Montezano, Augusto C.

AU - Belin de Chantemele, Eric Jacques

AU - Tostes, Rita C.

AU - Touyz, Rhian M.

PY - 2019/3/15

Y1 - 2019/3/15

N2 - Vascular inflammatory responses play an important role in several cardiovascular diseases. Of the many pro-inflammatory vasoactive factors implicated in this process, is aldosterone, an important mediator of vascular oxidative stress. Statins, such as atorvastatin, are cholesterol-lowering drugs that have pleiotropic actions, including anti-oxidant properties independently of their cholesterol-lowering effect. This study investigated whether atorvastatin prevents aldosterone-induced VSMC inflammation by reducing reactive oxygen species (ROS) production. Vascular smooth muscle cells (VSMC) from WKY rats were treated with 1 μM atorvastatin for 60 min or for 72 h prior to aldosterone (10 -7 mol/L) stimulation. Atorvastatin inhibited Rac1/2 and p47phox translocation from the cytosol to the membrane, as well as reduced aldosterone-induced ROS production. Atorvastatin also attenuated aldosterone-induced vascular inflammation and macrophage adhesion to VSMC. Similarly EHT1864, a Rac1/2 inhibitor, and tiron, ROS scavenger, reduced macrophage adhesion. Through its inhibitory effects on Rac1/2 activation and ROS production, atorvastatin reduces vascular ROS generation and inhibits VSMC inflammation. Our data suggest that in conditions associated with aldosterone-induced vascular damage, statins may have vasoprotective effects by inhibiting oxidative stress and inflammation.

AB - Vascular inflammatory responses play an important role in several cardiovascular diseases. Of the many pro-inflammatory vasoactive factors implicated in this process, is aldosterone, an important mediator of vascular oxidative stress. Statins, such as atorvastatin, are cholesterol-lowering drugs that have pleiotropic actions, including anti-oxidant properties independently of their cholesterol-lowering effect. This study investigated whether atorvastatin prevents aldosterone-induced VSMC inflammation by reducing reactive oxygen species (ROS) production. Vascular smooth muscle cells (VSMC) from WKY rats were treated with 1 μM atorvastatin for 60 min or for 72 h prior to aldosterone (10 -7 mol/L) stimulation. Atorvastatin inhibited Rac1/2 and p47phox translocation from the cytosol to the membrane, as well as reduced aldosterone-induced ROS production. Atorvastatin also attenuated aldosterone-induced vascular inflammation and macrophage adhesion to VSMC. Similarly EHT1864, a Rac1/2 inhibitor, and tiron, ROS scavenger, reduced macrophage adhesion. Through its inhibitory effects on Rac1/2 activation and ROS production, atorvastatin reduces vascular ROS generation and inhibits VSMC inflammation. Our data suggest that in conditions associated with aldosterone-induced vascular damage, statins may have vasoprotective effects by inhibiting oxidative stress and inflammation.

KW - Inflammation

KW - Mineralocorticoids

KW - Redox signaling

KW - Statins

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=85061227528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061227528&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2019.01.043

DO - 10.1016/j.lfs.2019.01.043

M3 - Article

VL - 221

SP - 29

EP - 34

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

ER -